Ad is loading...
MENU

ENTA Enanta Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of drugs and other pharmaceuticals products

Industry Biotechnology
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ENTA is expected to report earnings to rise 8.41% to -115 cents per share on November 25

Enanta Pharmaceuticals ENTA Stock Earnings Reports
Q3'24
Est.
$-1.16
Q2'24
Beat
by $0.36
Q1'24
Missed
by $0.13
Q4'23
Missed
by $1.75
Q3'23
Beat
by $0.79
The last earnings report on August 05 showed earnings per share of -107 cents, beating the estimate of -142 cents. With 1.00M shares outstanding, the current market capitalization sits at 197.90M.
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMRX14.740.27
+1.87%
Hartford Small Cap Value R3
GCSSX30.470.55
+1.84%
Goldman Sachs Small Cap Eq Insghts Svc
MGRFX22.500.23
+1.03%
MassMutual Mid Cap Growth R5
EIVFX14.790.12
+0.82%
Allspring Special Large Cap Value R6
UIVQX12.670.09
+0.72%
MFS Intrinsic Value R4

ENTA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with INZY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+0.32%
INZY - ENTA
42%
Loosely correlated
+4.46%
ARWR - ENTA
41%
Loosely correlated
+1.42%
ETNB - ENTA
41%
Loosely correlated
+4.53%
GBIO - ENTA
40%
Loosely correlated
+3.79%
KROS - ENTA
39%
Loosely correlated
+3.86%
More